Cancer, Medical Devices, Neuromodulation, Precision Medicine, Medtech.
most viable option for a range of conditions, from targeting difficult-to-access cancers to managing chronic pain or hypertension through selective nerve deactivation. Yet, even with all this potential, ablation modalities are typically not first-line treatments because patient-to-patient